November 9, 2013Open Access

APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Renal risk variants in APOL1 were associated with the higher rates of end-stage renal disease and progression of chronic kidney disease that were observed in black patients as compared with white patients, regardless of diabetes status. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.).

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Parsa et al. (Sat,) studied this question.

synapsesocial.com/papers/69d5721d75589c71d767e4ee https://doi.org/https://doi.org/10.1056/nejmoa1310345

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1APOL1 and kidney disease2012 · 56 citations
2Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>2002 · 2,044 citations
3The Chronic Renal Insufficiency Cohort (CRIC) Study2003 · 652 citations
4APOL1 Variants Associate with Increased Risk of CKD among African Americans2013 · 262 citations
5Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene2010 · 648 citations

Me gusta

Guardar

Ver artículo completo